SC
IDYA icon

Samlyn Capital’s IDEAYA Biosciences IDYA Stock Holding History

Samlyn Capital’s Portfolio IDYA Stock Details IDYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-791,266
Closed -$13M – 87
2025
Q1 		$13M Sell
791,266
-1,133
-0.1% -$24.1K 0.19% 72
2024
Q4 		$20.4M Sell
792,399
-24,908
-3% -$705K 0.31% 77
2024
Q3 		$25.9M Buy
817,307
+205,487
+34% +$7.79M 0.39% 68
2024
Q2 		$21.5M Buy
611,820
+130,595
+27% +$5.17M 0.36% 75
2024
Q1 		$21.1M Buy
+481,225
New +$20.7M 0.35% 74

Other funds holding IDYA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return

Samlyn Capital's IDYA Position: Q2 2025 in Review

Samlyn Capital sold out of IDEAYA Biosciences (IDYA) in Q2 2025, closing a stake of 791,266 shares — an estimated $13M sold.

Samlyn Capital first reported a position in IDYA in Q1 2024 and held it in 5 quarters. The position peaked at $25.9M in Q3 2024. 204 funds tracked by Wall St. Rank hold IDYA as of Q2 2025.

  • Samlyn Capital reported no remaining IDEAYA Biosciences position as of Q2 2025 after selling out during the quarter.
  • Samlyn Capital sold 791,266 IDEAYA Biosciences shares in Q2 2025, an estimated $13M.
  • Samlyn Capital first reported a position in IDEAYA Biosciences in Q1 2024 and held it in 5 quarters.
  • Samlyn Capital's IDEAYA Biosciences position peaked at $25.9M in Q3 2024.
  • 204 funds tracked by Wall St. Rank held IDEAYA Biosciences as of Q2 2025.

Based on Samlyn Capital's 13F filing for Q2 2025, filed 14 Aug 2025.